Improved oral bioavailability of cyclosporin A in male Wistar rats. Comparison of a Solutol HS 15 containing self-dispersing formulation and a microsuspension.
暂无分享,去创建一个
[1] J. Elashoff,et al. Postcibal Gastric Emptying of Pancreatin Pellets: Effects of Dose and Meal Oil , 2001, Digestive Diseases and Sciences.
[2] Beate Bittner,et al. Intravenous administration of poorly soluble new drug entities in early drug discovery: the potential impact of formulation on pharmacokinetic parameters. , 2002, Current opinion in drug discovery & development.
[3] S. Benita,et al. Self-dispersing lipid formulations for improving oral absorption of lipophilic drugs. , 2000, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[4] M. Maurin,et al. Improved oral bioavailability of the hypocholesterolemic DMP 565 in dogs following oral dosing in oil and glycol solutions. , 1997, Biopharmaceutics & drug disposition.
[5] Morton B. Brown,et al. Role of intestinal P‐glycoprotein (mdr1) in interpatient variation in the oral bioavailability of cyclosporine , 1997, Clinical pharmacology and therapeutics.
[6] G. Koren. Bias against the null hypothesis in maternal‐fetal pharmacology and toxicology , 1997, Clinical pharmacology and therapeutics.
[7] C. Beglinger,et al. Relevance of p‐glycoprotein for the enteral absorption of cyclosporin A: in vitro‐in vivo correlation , 1996, British journal of pharmacology.
[8] S. Friman,et al. A New Microemulsion Formulation of Cyclosporin , 1996, Clinical pharmacokinetics.
[9] L. Benet,et al. The effect of water‐soluble vitamin E on cyclosporine pharmacokinetics in healthy volunteers , 1996, Clinical pharmacology and therapeutics.
[10] J. Coon,et al. Reversal of multi‐drug resistance in vitro by fatty acid PEG fatty acid diesters , 1996, International journal of cancer.
[11] D. Niese,et al. Safety and tolerability of a new oral formulation of cyclosporin A, Sandimmun Neoral, in renal transplant patients , 1994, Transplant international : official journal of the European Society for Organ Transplantation.
[12] J. Kovarik,et al. Blood cyclosporin A and metabolite kinetic profiles after administration of Sandimmune soft gelatine capsules and Neoral in transplant recipients. , 1994, Transplantation proceedings.
[13] D. Grant,et al. Potential for CsA-Neoral in organ transplantation. , 1994, Transplantation proceedings.
[14] J. Kovarik,et al. Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation. , 1994, Journal of pharmaceutical sciences.
[15] M O Karlsson,et al. Dose dependent absorption and linear disposition of cyclosporin A in rat , 1994, Biopharmaceutics & drug disposition.
[16] A. Fahr. Cyclosporin Clinical Pharmacokinetics , 1993, Clinical pharmacokinetics.
[17] Y. Tanigawara,et al. Human P-glycoprotein transports cyclosporin A and FK506. , 1993, The Journal of biological chemistry.
[18] C. Beglinger,et al. The absorption site of cyclosporin in the human gastrointestinal tract. , 1992, British journal of clinical pharmacology.
[19] J. Dressman,et al. Unusual solubility behaviour of cyclosporin A in aqueous media , 1991, The Journal of pharmacy and pharmacology.
[20] D. Back,et al. Cyclosporin metabolism by the gastrointestinal mucosa. , 1991, British journal of clinical pharmacology.
[21] W. Ritschel,et al. Improvement of peroral absorption of cyclosporine A by microemulsions. , 1990, Methods and findings in experimental and clinical pharmacology.
[22] D. V. van Thiel,et al. Effect of bile on cyclosporin absorption in liver transplant patients. , 1988, British journal of clinical pharmacology.
[23] R. Venkataramanan,et al. Clinical Pharmacokinetics of Cyclosporin , 1986, Clinical Pharmacokinetics.
[24] D. Holt,et al. The effect of vehicle on the oral absorption of cyclosporin. , 1986, British journal of clinical pharmacology.
[25] B D Kahan,et al. INDIVIDUALIZATION OF CYCLOSPORINE THERAPY USING PHARMACOKINETIC AND PHARMACODYNAMIC PARAMETERS , 1985, Transplantation.
[26] N. Shibata,et al. Promotion of the selective lymphatic delivery of cyclosporin A by lipid-surfactant mixed micelles. , 1985, Journal of pharmacobio-dynamics.
[27] M. Lemaire,et al. Apparent dose-dependent oral absorption of cyclosporin A in rats. , 1984, Biopharmaceutics & drug disposition.
[28] M. Lemaire,et al. Intestinal lymphatic absorption of cyclosporin A following oral administration in an olive oil solution in rats. , 1983, Biopharmaceutics & drug disposition.
[29] C. T. Ueda,et al. Preliminary observations on the absorption of liposome-encapsulated drug by the intestinal lymphatics. , 1981, Research communications in chemical pathology and pharmacology.